Familial Hemophagocytic Lymphohistiocytosis Presenting as Hydrops Fetalis

被引:7
作者
Iwatani, Sota [1 ]
Uemura, Kazuya [1 ]
Mizobuchi, Masami [1 ]
Yoshimoto, Seiji [1 ]
Kawasaki, Keiichiro [2 ]
Kosaka, Yoshiyuki [2 ]
Hori, Masayuki [3 ]
Yasumi, Takahiro [3 ]
Nakao, Hideto [1 ]
机构
[1] Hyogo Prefectural Kobe Childrens Hosp, Dept Neonatol, Kobe, Hyogo, Japan
[2] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
来源
AJP REPORTS | 2015年 / 5卷 / 01期
关键词
familial hemophagocytic lymphohistiocytosis; hydrops fetalis; hepatosplenomegaly; cytopenia; immunosuppressive chemotherapy;
D O I
10.1055/s-0034-1544110
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Familial hemophagocytic lymphohistiocytosis (FLH) is an autosomal recessive disorder of immune regulation that leads to a hyperinflammatory syndrome. Fetal onset FHL is extremely rare and is considered to be the most severe form of FHL. Case We report a preterm case of FHL that presented as hydrops fetalis. The infant was treated with a chemotherapy regimen based on the HLH-2004 protocol from the third day of life. However, he had persistent cytopenia and died on the 18th day of life due to bacteremia. The detection of defective perforin expression in the patient's natural killer cells and mutations in the PRF1 gene resulted in a molecular diagnosis of FHL. Conclusion We suggest that early diagnosis and the development of an appropriate immunosuppressive strategy that can induce and maintain remission until hematopoietic stem cell transplantation can be performed are required to improve the outcomes of fetal onset FHL.
引用
收藏
页码:E22 / E24
页数:3
相关论文
共 12 条
  • [1] Arico M, 1996, LEUKEMIA, V10, P197
  • [2] Hemophagocytic Lymphohistiocytosis With Munc13-4 Mutation: A Cause of Recurrent Fatal Hydrops Fetalis
    Bechara, Elie
    Dijoud, Frederique
    de Saint Basile, Genevieve
    Bertrand, Yves
    Pondarre, Corinne
    [J]. PEDIATRICS, 2011, 128 (01) : E251 - E254
  • [3] HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
    Henter, Jan-Inge
    Horne, AnnaCarin
    Arico, Maurizio
    Egeler, R. Maarten
    Filipovich, Alexandra H.
    Imashuku, Shinsaku
    Ladisch, Stephan
    McClain, Ken
    Webb, David
    Winiarski, Jacek
    Janka, Gritta
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (02) : 124 - 131
  • [4] Fetal and neonatal histiocytoses
    Isaacs, H
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 47 (02) : 123 - 129
  • [5] Infection- and malignancy-associated hemophagocytic syndromes - Secondary hemophagocytic lymphohistiocytosis
    Janka, G
    Imashuku, S
    Elinder, G
    Schneider, M
    Henter, JI
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) : 435 - +
  • [6] Familial and acquired hemophagocytic lymphohistiocytosis
    Janka, Gritta E.
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (02) : 95 - 109
  • [7] Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis With Alemtuzumab
    Marsh, Rebecca A.
    Allen, Carl E.
    McClain, Kenneth L.
    Weinstein, Joanna L.
    Kanter, Julie
    Skiles, Jodi
    Lee, Nadine D.
    Khan, Shakila P.
    Lawrence, Julia
    Mo, Jun Q.
    Bleesing, Jack J.
    Filipovich, Alexandra H.
    Jordan, Michael B.
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 (01) : 101 - 109
  • [8] Congenital Hemophagocytic Lymphohistiocytosis in a Preterm Infant: Cytokine Profile and a Review of the Disease
    Maruyama, Asami
    Takahashi, Naoto
    Gunji, Yuji
    Morimoto, Akira
    Yada, Yukari
    Koike, Yasunori
    Momoi, Mariko Y.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (05) : E209 - E212
  • [9] Pachlopnik SJ, 2009, EMBO MOL MED, V1, P112, DOI DOI 10.1002/EMMM.200900009
  • [10] Mesenchymal Stromal Cells: Current Understanding and Clinical Status
    Salem, Husein K.
    Thiemermann, Chris
    [J]. STEM CELLS, 2010, 28 (03) : 585 - 596